Evidence map›Paper›PMID 32706689›Full record

ArticleJMIR mHealth and uHealth2020

Evaluation Criteria for Weight Management Apps: Validation Using a Modified Delphi Process.

Noemí Robles, Elisa Puigdomènech Puig, Corpus Gómez-Calderón, Francesc Saigí-Rubió, Guillem Cuatrecasas Cambra, Alberto Zamora, Montse Moharra, Guillermo Paluzié, Mariona Balfegó, Carme Carrion

Erratum issuedAbstract readValidation Study
In one paragraph

Article in JMIR mHealth and uHealth, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Codesign and Feasibility Testing of a Tool to Evaluate Overweight and Obesity Apps.International journal of environmental research and public health · 2022
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Noemí Robles *eHealth Lab Research Group, Universitat Oberta de Catalunya, Barcelona, Spain.ORCID 0000-0003-0740-9098
Elisa Puigdomènech Puig *eHealth Lab Research Group, Universitat Oberta de Catalunya, Barcelona, Spain.ORCID 0000-0002-1671-0248
Corpus Gómez-Calderón *Marina Salud, Alicante, Spain.ORCID 0000-0001-5293-8082
Francesc Saigí-Rubió *Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.ORCID 0000-0001-9616-1551
Guillem Cuatrecasas Cambra *Clínica Sagrada Família, CPEN SL Servei d'Endocrinologia i Nutrició, Barcelona, Spain.ORCID 0000-0002-4133-0722
Alberto Zamora *Corporació de Salut del Maresme i la Selva, Hospital de Blanes, Blanes, Spain.ORCID 0000-0001-6907-0654
Montse Moharra *Agència de Qualitat i Avaluació Sanitàries de Catalunya, Barcelona, Spain.ORCID 0000-0003-3332-7205
Guillermo Paluzié *Corporació de Salut del Maresme i la Selva, Hospital de Blanes, Blanes, Spain.ORCID 0000-0002-5808-6041
Mariona Balfegó *Clínica Sagrada Família, CPEN SL Servei d'Endocrinologia i Nutrició, Barcelona, Spain.ORCID 0000-0003-2229-5463
Carme Carrion *eHealth Lab Research Group, Universitat Oberta de Catalunya, Barcelona, Spain.ORCID 0000-0003-1479-7551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of apps for weight management has increased over recent years; however, there is a lack of evidence regarding the efficacy and safety of these apps. The EVALAPPS project will develop and validate an assessment instrument to specifically assess the safety and efficacy of weight management apps.

objectiveThe aim of this study was to reach a consensus among stakeholders on a comprehensive set of criteria to guide development of the EVALAPPS assessment instrument. A modified Delphi process was used in order to verify the robustness of the criteria that had been identified through a literature review and to prioritize a set of the identified criteria.

methodsStakeholders (n=31) were invited to participate in a 2-round Delphi process with 114 initial criteria that had been identified from the literature. In round 1, participants rated criteria according to relevance on a scale from 0 ("I suggest this criterion is excluded") to 5 ("This criterion is extremely relevant"). A criterion was accepted if the median rating was 4 or higher and if the relative intraquartile range was equal to 0.67 or lower. In round 2, participants were asked about criteria that had been discarded in round 1. A prioritization strategy was used to identify crucial criteria according to (1) the importance attributed by participants (criteria with a mean rating of 4.00 or higher), (2) the level of consensus (criteria with a score of 4 or 5 by at least 80% of the participants).

resultsThe response rate was 83.9% (26/31) in round 1 and 90.3% (28/31) in round 2. A total of 107 out of 114 criteria (93.9%) were accepted by consensus-105 criteria in round 1 and 2 criteria in round 2. After prioritization, 53 criteria were deemed crucial. These related mainly to the dimensions of security and privacy (13/53, 24.5%) and usability (9/53, 17.0%), followed by activity data (5/53, 9.4%), clinical effectiveness (5/53, 9.4%), and reliability (5/53, 9.4%).

conclusionsResults confirmed the robustness of the criteria that were identified, with those relating to security and privacy being deemed most relevant by stakeholders. Additionally, a specific set of criteria based on health indicators (activity data, physical state data, and personal data) was also prioritized.

Indexed as

Delphi TechniqueWeight LossAdultAgedConsensusFemaleHumansMaleMiddle AgedReproducibility of ResultsTreatment OutcomeYoung AdultconsensusDelphi techniquemHealthobesityoverweighttechnology assessment

Identifiers

PMID32706689
PMCPMC7407251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.